ClinicalTrials.Veeva

Menu

Distinct Sources of Supplementary Protein in the Resistance Exercise Training-induced Adaptations

U

University of Sao Paulo General Hospital

Status

Completed

Conditions

Muscle Strength
Resistance Training
Diet Habit
Muscle, Skeletal
Dietary Supplements

Treatments

Dietary Supplement: Plant Protein
Dietary Supplement: Animal protein

Study type

Interventional

Funder types

Other

Identifiers

NCT05710614
66029522.3.0000.0068

Details and patient eligibility

About

This is a randomized controlled trial aimed to investigate the effects of different supplementary protein sources on muscle adaptations to resistance exercise. Young, healthy, recreationally active participants consuming an omnivorous diet with protein intake within recommended dietary allowance (RDA) (i.e.; 0.8-1.0 g.kg-1. d-1) will be recruited to undergo a 12-wk supervised resistance training program in combination with the intake of three 15-g daily doses (45g. d-1 total) of either a mixed plant- (i.e.; soy and pea protein) or animal-based (i.e.; whey protein) protein in drink form as a supplementary source of protein to their main meals of the day (i.e.; breakfast, lunch, and dinner). Before (PRE) and after (POST) the 12-wk intervention, participants will be assessed for body composition by dual-energy X-ray absorptiometry (DXA), muscle cross-sectional area (ultrasound) and fiber cross-sectional area (muscle biopsy), and maximal isotonic strength (1RM). Training consists of a resistance training (RT) program individually supervised by a researcher blinded to treatment in a laboratorial setting. Assessments will also be conducted in a blinded fashion.

Enrollment

40 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Physically active (according to the International Physical Activity Questionnaire (IPAQ)
  • Absence of any chronic condition that could preclude participation in a RT program or physical testing
  • Habitual protein consumption within RDA ≥ 0.8 ≤1.0 g.kg-1. d-1

Exclusion criteria

  • Prior history of anabolic steroids use, current or previous (≤ 3 m)
  • Use of ergogenic or protein-based supplements, current or previous (< 1 y)
  • Engagement in energy-restricted diets

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups

animal protein
Active Comparator group
Description:
Whey protein will be used as the active comparator for animal protein arm
Treatment:
Dietary Supplement: Animal protein
plant protein
Experimental group
Description:
A combination of pea and soy protein will be used as the experimental arm
Treatment:
Dietary Supplement: Plant Protein

Trial contacts and locations

1

Loading...

Central trial contact

Hamilton Roschel, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems